Clinical Trial Update: An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2, open-label, single-center trial evaluating the antibody Gastrimmune for antibody response, safety, and tolerability in advanced pancreatic cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gastrimmune

Snippet

Sponsor: Cancer Advances Inc. | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED